alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM TRANSCRYPT
INTERNATIONAL, INC.'S CONSOLIDATED STATEMENTS OF OPERATIONS AND CONSOLIDATED
BALANCE SHEETS AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLARS
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               DEC-31-1997
<EXCHANGE-RATE>                                      1
<CASH>                                          15,384
<SECURITIES>                                    15,900
<RECEIVABLES>                                   19,210
<ALLOWANCES>                                     2,417
<INVENTORY>                                     18,363
<CURRENT-ASSETS>                                72,448
<PP&E>                                          14,843
<DEPRECIATION>                                   3,582
<TOTAL-ASSETS>                                 106,694
<CURRENT-LIABILITIES>                           27,612
<BONDS>                                          2,758
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           129
<OTHER-SE>                                      75,261
<TOTAL-LIABILITY-AND-EQUITY>                   106,694
<SALES>                                         40,423
<TOTAL-REVENUES>                                40,423
<CGS>                                           26,106
<TOTAL-COSTS>                                   26,106
<OTHER-EXPENSES>                                26,039<F1>
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               (231)<F2>
<INCOME-PRETAX>                               (11,473)
<INCOME-TAX>                                     (524)
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (10,949)
<EPS-PRIMARY>                                   (1.09)
<EPS-DILUTED>                                   (1.09)
<FN>
<F1>Item includes a one time charge of in-process research and development costs of
$9.8 million.
<F2>Interest expense is net of $874 of interest income less $643 of interest
expense.
</FN>
        

</TABLE>
<TABLE> <S> <C>

<PAGE>

<ARTICLE>                     5
<LEGEND>
The schedule contains restated summary financial information extracted from the
Condensed Consolidated Statements of Operation for the Year Ended December 31,
1996 and the Condensed Consolidated Balance Sheet as of December 31, 1996 and is
qualified in its entirety by reference to such financial statements.
</LEGEND>
<RESTATED>
<MULTIPLIER>                                   1,000

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                              DEC-31-1996
<PERIOD-START>                                 JAN-01-1996
<PERIOD-END>                                   DEC-31-1996
<CASH>                                              48,680
<SECURITIES>                                             0
<RECEIVABLES>                                        3,187
<ALLOWANCES>                                            70
<INVENTORY>                                            151
<CURRENT-ASSETS>                                    56,445
<PP&E>                                              22,939
<DEPRECIATION>                                       1,809
<TOTAL-ASSETS>                                     181,754
<CURRENT-LIABILITIES>                               13,109
<BONDS>                                                516
<PREFERRED-MANDATORY>                                7,000
<PREFERRED>                                              1<F1>
<COMMON>                                                 7
<OTHER-SE>                                         155,946
<TOTAL-LIABILITY-AND-EQUITY>                       181,754
<SALES>                                              4,486
<TOTAL-REVENUES>                                    22,944
<CGS>                                                  821
<TOTAL-COSTS>                                       16,245
<OTHER-EXPENSES>                                     7,106
<LOSS-PROVISION>                                         0
<INTEREST-EXPENSE>                                       0
<INCOME-PRETAX>                                      5,767
<INCOME-TAX>                                        (1,236)
<INCOME-CONTINUING>                                  7,003
<DISCONTINUED>                                           0
<EXTRAORDINARY>                                          0
<CHANGES>                                                0
<NET-INCOME>                                         7,003
<EPS-PRIMARY>                                         1.11
<EPS-DILUTED>                                         1.02

<FN>
<F1> Represents par value of Reading Entertainment Series B Preferred Stock
</FN>

</TABLE>
<PAGE>  



PRICING SUPPLEMENT NO. 206 DATED                           Filed Pursuant to
February 29, 1996 TO PROSPECTUS DATED                      Rule 424(b)(5)
March 29, 1994 AS AMENDED BY PROSPECTUS                    File No. 33-51877
DATED October 14, 1995


                             CMS ENERGY CORPORATION

       General Term Notes (servicemark of J.W. Korth & Company), Series A
                   Due 9 Months to 25 Years from date of issue

       Except as set forth herein, the General Term Notes (servicemark of
J.W. Korth & Company) offered hereby (the "Notes") have such terms as are
described in the accompanying Prospectus dated October 14, 1995.

Aggregate Principal Amount:                   $  241,000.00     
Original Issue Date (Settlement Date)          March 5, 1996    
Stated Maturity Date:                          February 15, 2003
Issue Price to Public:                        100.00% of Principal Amount
Interest Rate:                                7.375% Per Annum
Interest Payment Dates:                       April 15 and monthly thereafter
                                              Commencing April 15, 1996
Survivor's Option:                            [ X ] Yes    [   ] No
Optional Redemption:                          [ X ] Yes    [   ] No
Initial Redemption Date:                      February 15, 1998
Redemption Price:                             Initially 101.00% of Principal
                                              Amount and 100.00% after the
                                              first anniversary of the Initial
                                              Redemption Date.

       Agent                                  Principal Amount of Notes
                                               Solicited by Each Agent
Prudential Securities Incorporated            $   20,000.00     
EVEREN Securities, Inc.                       $   25,000.00     
First of Michigan Corporation                 $   35,000.00     
Roney & Co.                                   $   15,000.00     
J.W. Korth & Company                          $  146,000.00     
       Total                                  $  241,000.00     

                                                Per Note
                                              Sold by Agents
                                               To Public           Total

Issue Price:                                  $1,000.00          $  241,000.00
Agent's Discount or Commission:               $    7.00          $    1,687.00
Maximum Dealer's Discount or
  Selling Concession:                         $   19.50          $    4,699.50
Proceeds to the Company:                      $  973.50          $  234,613.50

CUSIP Number:   12589QJU1   
<PAGE>
Exhibit
4.1


 


THE
BANK OF NEW YORK MELLON


NEW YORK’S
FIRST BANK-FOUNDED 1784 BY ALEXANDER HAMILTON


 


 


2
HANSON PLACE, 12TH FLOOR, BROOKLYN, N.Y. 11217


 


 


 


September
16, 2014


 


Hennion
& Walsh, Inc.


2001 Route
46, Waterview Plaza


Parsippany,
New Jersey 07054


 


Smart
Trust, New York Municipal Portfolio of Closed-End Funds Trust, Series 8


Dear
Sirs:


The
Bank of New York Mellon is acting as trustee for Smart Trust, New York Municipal Portfolio of Closed-End Funds Trust, Series 8
set forth above (the “Trust”). We enclosed a list of the Securities to be deposited in the Trust on the date
hereof. The prices indicated therein reflect our evaluation of such Securities as of close of business on September 16, 2014,
in accordance with the valuation method set forth in the Trust Indenture and Agreement. We consent to the reference to The Bank
of New York Mellon as the party performing the evaluations of the Trust Securities in the Registration Statement (No. 333-197696)
filed with the Securities and Exchange Commission with respect to the registration of the sale of the Trust Units and to the filing
of this consent as an exhibit thereto.


 


 


Very
truly yours,


 


/s/
GERARDO CIPRIANO _______________ 


Gerardo
Cipriano


Vice
President
**Exhibit
      32.2**




**CERTIFICATION
      PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**


**SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002**




Pursuant
      to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of
      2002, the undersigned officer of ecoSolutions Intl (the “Company”) hereby
      certifies that, to the best of her knowledge:




(iii)  The
      Quarterly Report on Form 10-Q of the Company for the quarter ended March 31,
      2008 (the “Report”) fully complies with the requirements of Section 13(a) or
      Section 15(d), as applicable, of the Securities Exchange Act of 1934, as
      amended; and




(iv)  The
      information contained in the Report fairly presents, in all material respects,
      the financial condition and results of operations of the Company.





Date:
                August 14, 2008
            By:
            /s/
              Jane EmkesJane
                Emkes
              Chief
                Financial Officer
Page 1 of 2

Miller, Diane M.

From: .

Sent: Friday, October 12, 2001 1:26 PM
To: NIOCINDOCKET@CDC.GOV

Ce:

Subject: RE: Work related radiation exposure

Messieurs;
| am the daughter of Lt.Col.[(ret)(Deceased)]

. He was discharged (with Honors) @30% medical
work related cancer from Hodgkin's in 1963. This was
directly related to his Intelligence Assignment which
posted the entire family to the Philippine Islands for 24
months (Hardship duty-Max stay was to be 18 MOS)
where he accomplished his orders "To get the 35 year
good will pact," prohibiting the Philippines from suit
against the US for any reason signed by President
MagSiSi. When CDC determined AILD, "Project
Bravo" (detonation of Hydrogen Bomb, 10,000 x more
powerful than the atomic bomb dropped on Hiroshima),
on the Bikini Atolls was still classified as Top Secret.
Thus, he received Plasmaphoresis for 3 years which
gave him another 13 years of life, which ended in Lung
Cancer. My eldest Brother, (NATIONAL MERIT SCHOLAR
AND PHYSICIST, (disabled) died at age 44 of sepsis of
abdominal cavity, and heart failure due to antibiotics
given to treat sepsis. The cdc has sent Medline search
showing that my baby sister and | both have AILD
was an infant and ate only native food with her AMA.

and | were in Puberty during the two years of
massive exposure to radiation which had contaminated
the Philippine Islands. | have hard copy on Project
Bravo, Mom & Dad's medical records which were
ongoing post Philippines reflect the entire family has

10/19/2001


Page 2 of 2

suffered from exposure. Dad also taught a course on
radiation at the Pentagon and brought home a lead
thermos with a radiated furry animal in it. The class was
so top secret that he was required to bring the cylinder

inside. Dad had to have new front teeth growing
sideways (900) extracted from his jaw. So far, insurance
has denied all care. Can you help us (military
dependents who had no work contract with the Federal
Government, but are suffering as a result of Love for and
Loyalty to our Country)? My Father was head of

Military records proving all statements can
be provided upon request. | pray that our country will
give some recognition to the children who have suffered
all their lives without knowing why or what was
happening to our bodies. Radiation necrosis of teeth
have required removal, bone tissue is warping as a
result of dentures. The list of body system problems and
the MD Dxs can also be provided. Dad, ‘&lhave
identical problems documented in our medical records.
Thank you for your time and attention to my request.

Dad's DNA had been changed prior to birth of : .
who was born with hips w/out cup to hold hip bones
together.

Please respond to so 1do not
miss your response.

Sincerely,

Candace Elizabeth Benson Peyer-Bellows

10/19/2001
EXHIBIT 32.2


                        CERTIFICATION PURSUANT TO
                         18 U.S.C. SECTION 1350,
                         AS ADOPTED PURSUANT TO
               SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


    In connection with the Quarterly Report of Monarch Services, Inc. (the
"Company") on Form 10-QSB for the quarter ending July 31, 2006, as filed
with the Securities and Exchange Commission on the date hereof (the "Report"),



I, Marshall Chadwell, the Chief Financial Officer of the Company, certify,
pursuant to and for purposes of 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my
knowledge:

    (1)  The Report fully complies with the requirements of Sections 13(a)
         or 15(d) of the Securities Exchange Act of 1934; and

    (2)  The information contained in the Report fairly presents, in all
         material respects, the financial condition and results of
         operations of the Company.

Date: September 8, 2006

/s/   Marshall Chadwell
----------------------------
Marshall Chadwell
Chief Financial Officer
# In the United States Court of Federal Claims

OFFICE OF SPECIAL MASTERS No. 15-221V Filed: April 27, 2016 Not for Publication

************************************* BRANDENE LAPORTE , * * Petitioner, * * v. * * SECRETARY OF HEALTH * AND HUMAN SERVICES, * * Respondent. * * ************************************* Maximillian J. Muller

, Dresher, PA , for petitioner. Justine E. Walters , Washington, DC, for respondent.

MILLMAN, Special Master

DECISION AWARDING DAMAGES 1

On April 26, 2016 , the parties filed the attached stipulation in which they agreed to settle this case and described the settlement terms. Petitioner alleges that she suffered transverse myelitis (“TM”) caused by her March 5, 2012 receipt of the tetanus, diphtheria, acellular pertussis (“Tdap”) vaccine. Respondent denies that the Tdap vaccine caused petitioner’s TM or any other injury. Nonetheless, the parties agreed to resolv e this matter informally.

1 Because this unpublished decision contains a reasoned explanation f or the special master’s action in this case, the special master intends to post this unpublished decision on the United States Court of Federal Claims’ website, in accordance w ith the E- Gov ernment Act of 2002, 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic Government Services). Vaccine Rule 18(b) states that all decisions of the special masters will be made available to the public unless they contain trade secrets or commercial or financial information that is privileged and confidential, or medical or similar information whose disclosure would constitute a clearly unwarranted invasion of privacy. When such a decision is filed, petitioner has 14 days to identify and move to redact such information prior to the document = s disclosure. If the special master, upon review, agrees t hat the identified material fits within the banned categories listed above, the special master shall redact such material from public access. Damages decision based on stipulation; transverse myelitis (“TM”); tetanus, diphtheria, acellular pertussis (“Tdap”) vaccine2 The undersigned finds the terms of the stipulation to be reasonable. The court hereby adopts the parties’ said stipulation, attached hereto, and awards compensation in the amount and on the terms set forth therein. Pursuant to the stipulation, the court awards a lump sum of $140,000.00 , representing reimbursement for all damages that would be available under 42 U.S.C. § 300aa-15(a) (2012). The award shall be in the form of a check payable to petitioner in the amount of $140,000.00

.

In the absence of a motion for review filed pursuant to RCFC Appendix B, the clerk of the court is directed to enter judgment herewith. 2

IT IS SO ORDERED.

Dated: April 27, 2016 s/ Laura D. Millman Laura D. Millman

Special Master

2 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by each party , either separately or jointly, filing a notice renouncing the right to seek review.
AGENDA

Advisory Board on Radiation and Worker Health 

Teleconference of the

Science Issues Work Group

October 12, 2011

Conference Call Number: 1-866-659-0537

Participant Pass Code: 9933701

2:00 p.m Eastern Time Welcome and roll-call/introductions 

1) Discussion of scope of task for the Work Group 

2) Discussion of priorities and interests

(NIOSH-enumerated list of topics; other issues)

3) Process for review, discussion, reporting to Board
EXHIBIT 32.1




CERTIFICATION PURSUANT TO


18 U.S.C. SECTION 1350


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002






In connection with the Quarterly Report of Sungro Minerals, Inc. (the “Company”) on Form 10-Q for the quarter ended August 31, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, in the capacities and on the dates indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:




1.
The Quarterly Report on Form 10-Q of the Company for the period ended August 31, 2010 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended and




2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.




Date:           October 20, 2010
By:
/s/ Frederick J. Pucillo, Jr.Name:
Frederick J. Pucillo, Jr.Title:
Chief Executive Officer







A signed original of this written statement required by Section 906, or other document authentications, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided Sherb & Co., LP and will be retained by Sungro Minerals, Inc., and furnished to the Securities and Exchange Commission or its staff upon request.
[DO NOT PUBLISH]

IN THE UNITED STATES COURT OF APPEALS
FOR THE ELEVENTH CIRCUIT

________________________ No. 16

- 12834 Non

- Argument Calendar

________________________ D.C. Docket No. 4:16

- cv - 00110

- WS

- CAS

RONALD DAVID JONES, Plaintiff

- Appellant,

versus CHRIST TOWN MINISTRIES, Defendant

- Appellee.

________________________ Appeal from the United States District Court for the Northern District of Florida

________________________ (October 28, 2016) Before WILSON , JULIE CARNES, and JILL PRYOR Circuit Judges.
PE R CURIAM:

Case: 16-12834 Date Filed: 10/28/2016 Page: 1 of 32 Ronald David Jones , proceeding pro se and in forma pauperis , appeals the dismissal of his amended complaint filed pursuant to 42 U.S.C. § 1983 for failure
to state a claim

. On appeal, Jones argues t hat t he district court erred in d ismissing his amended complaint, which alleged that Christ Town Ministries intentiona l l y fail e d to send his internship paperwork to Grand Canyon University because of his race and religious beliefs , thereby violating his First and Fourteenth Amendment
R igh ts

. Section 1983 does not create substantive rights, but instead “ provides a remedy for deprivations of federal statutory and constitutional rights. ” Almand v. DeKalb Cty., Ga. , 103 F.3d 1510, 1512 (11th Cir. 1997). A plaintiff suing under § 1983 mu st show that he was deprived of a federal statutory or constitutional right by a person acting “ under color of state law. ” Focus on the Family v. Pinellas Suncoast Transit Auth. , 344 F.3d 1263, 1276

– 77 (11th Cir. 2003) . Section 1983 does not apply to pur ely private conduct , but it can apply to the actions of private actors if: (1) the acto r performed a function that is traditionally the exclusive prerogative of the state; (2) the state has coerced or significantly encouraged the action taken by the privat e party; or (3) the state has such a relationship of interdependence with the private actor that it was a joint participant in the action. Id

. at 1277

. Case: 16-12834 Date Filed: 10/28/2016 Page: 2 of 33 Jones’s amended complaint failed to show that Christ Town Ministries was a state actor, or allege facts that would satisfy any of the three methods by which a private actor can be deemed to have acted under color of state law. Focus on the Family , 344 F.3 d at 1276

- 77

. Thus, the district court did not err in dismissing Jones’s amended complaint for failure to state a claim upon which relief can be granted.

AFFIRMED. Case: 16-12834 Date Filed: 10/28/2016 Page: 3 of 3
[Federal Register Volume 73, Number 10 (Tuesday, January 15, 2008)]
[Notices]
[Pages 2496-2497]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 08-107]


-----------------------------------------------------------------------

FEDERAL RESERVE SYSTEM


Federal Open Market Committee; Domestic Policy Directive of 
December 11, 2007

    In accordance with Sec.  271.25 of its rules regarding availability 
of information (12 CFR part 271), there is set forth below the domestic 
policy directive issued by the Federal Open Market Committee at its 
meeting held on December 11, 2007.\1\
---------------------------------------------------------------------------

    \1\ Copies of the Minutes of the Federal Open Market Committee 
meeting on December 11, 2007, which includes the domestic policy 
directive issued at the meeting, are available upon request to the 
Board of Governors of the Federal Reserve System, Washington, DC 
20551. The minutes are published in the Federal Reserve Bulletin and 
in the Board's annual report.
---------------------------------------------------------------------------

    The Federal Open Market Committee seeks monetary and financial 
conditions that will foster price stability and promote sustainable 
growth in output. To further its long-run objectives, the Committee in 
the immediate future seeks conditions in reserve markets consistent 
with reducing the federal funds rate at an average of around 4\1/4\ 
percent.


[[Page 2497]]


    By order of the Federal Open Market Committee, January 9, 2008.
Brian F. Madigan,
Secretary, Federal Open Market Committee.
[FR Doc. 08-107 Filed 1-14-08; 8:45 am]
BILLING CODE 6210-01-M